Products

08August

Hyris' new T-cell Test is finally available to EU Countries to easily map patients' cellular immunity to SARS-CoV-2.

Hyris' new T-cell Test is finally available to EU Countries to easily map patients' cellular immunity to SARS-CoV-2.

After months of experimentation in partnership with some world-class schools of medicine and top-tier diagnostic providers, our much-anticipated T-Cell Test based on innovative qPCR technology is finally available for the European market with a CE-IVD mark. The new Test will change the way laboratories and diagnostic providers track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of Hyris System™.

Posted in bKIT, Products

13June

A new T-cell activation assay based on Hyris technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity.

A new T-cell activation assay based on Hyris technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity.

A scientific paper recently published in Nature Biotechnology reveals new research regarding how we track and monitor T-cell patients’ immunity to SARS-CoV-2, leveraging the unique characteristics of Hyris System™. The study results from a joint effort of an international research team from the Icahn School of Medicine at Mount Sinai, Singapore Duke-NUS Medical School, laboratory diagnostic service providers Synlab, and Hyris.

Posted in Products

21December

Hyris presented its new, disruptive T-Cell test at the international conference "A-Wish", fully embracing the Immunology sector to better fight COVID-19 and beyond.

Hyris presented its new, disruptive T-Cell test at the international conference

On December 17th 2021 Hyris presented its new test to detect the body's T Cell immune response to SARS-CoV-2 on 17 December 2021, at "A-WISH", Alicante-Winter Immunology Symposium in Health, which addressed strategies for the COVID-19 response and the development of the vaccines against SARS-CoV-2.

Posted in Products

02December

Hyris releases its new Demo to better support all prospect users of its portable and reliable molecular test for diagnosing SARS-CoV-2 into human subjects.

Hyris releases its new Demo to better support all prospect users of its portable and reliable molecular test for diagnosing SARS-CoV-2 into human subjects.

With the SARS-CoV-2 pandemic still causing further disruption of public security and companies’ workflows worldwide, Hyris keeps supporting medical professionals and researchers testing the presence of SARS-CoV-2 into human beings. A fresh, new demo immed

Posted in Products

14October

Hyris new Test can quickly detect the body's T Cell immune response to SARS-CoV-2.

Hyris new Test can quickly detect the body's T Cell immune response to SARS-CoV-2.

Hyris developed a rapid T-Cell test, which leverages the power of the Hyris SystemTM to track patients' immunity levels to SARS-CoV-2 for research and global clinical use. The new test has been brought to market after having inked an exclusive licensing agreement with Singapore Duke-NUS Medical School.

Posted in Products, Events

17February

Generon - Hyris

Generon - Hyris

Hyris and Generon: new strategic cooperation agreement.

Posted in Products, Technology, Research

13February

Indena Genetically Validates Bilberry Extract

Indena Genetically Validates Bilberry Extract

Various reports have estimated approximately 30% of biomass materials sold for human consumption are not what is declared on the label. As such, Indena has applied DNA barcoding to validate the content of its natural ingredients—starting with bilberry.

Posted in Products, Technology, Research

25June

Portable device detects dengue, Zika in individual mosquitoes

Portable device detects dengue, Zika in individual mosquitoes

SAN FRANCISCO — Researchers developed a highly sensitive quantitative PCR, or qPCR, method for the detection and quantitation of dengue and Zika virus in individual mosquitoes using the portable Hyris bCUBE device, introducing a new tool for mosquito surveillance in areas facing outbreaks, according to data presented at ASM Microbe.

Posted in Products, Technology, Research

24June

EMMAC to partner with Hyris Ltd to develop Unique Real-Time Phyto-Cannabinoid Rich technology for the specific identification of proprietary cultivars of Cannabis subsp

EMMAC to partner with Hyris Ltd to develop Unique Real-Time Phyto-Cannabinoid Rich technology for the specific identification of proprietary cultivars of Cannabis subsp

London, 24 June 2019: EMMAC, the European independent medical cannabis company, is pleased to announce an exclusive collaboration with Hyris Ltd, a UK-based biotechnology company, to develop a comprehensive library of genetic profiles of existing cannabis varieties, and to industrialise DNA-based methods for the identification of its unique branded cultivars.

 

Posted in Products, Technology, Research

19August

bCUBE 2.0 now available for sale

bCUBE 2.0 now available for sale

Hyris Ltd officially launches today a totally renewed version of its flagship product: bCUBE 2.0, a miniaturized, portable DNA-testing laboratory. The new revision comes with a full aluminium casing of inspiring design, smaller footprint and weight (10x10x12 cm, 1.15 kg), enhanced connectivity (WiFi/Ethernet) and embedded cloud services. Technical information, applications and general product info are available at www.hyris.net.

Posted in bCUBE, Products

30March

Hyris bCUBE 1.0 available for sale

Hyris bCUBE 1.0 available for sale

The Smartphone of Molecular Diagnostics


Hyris Ltd officially launches today its flagship product: a miniaturized, portable DNA-testing laboratory. Technical information, applications and general product info are available at www.hyris.net.

Posted in bCUBE, Products, Technology

15March

Hyris Ltd launches its Flavescence Doree kit

Hyris Ltd launches its Flavescence Doree kit

Following the positive completion of independent testing of its FD detection kit, Hyris Ltd announces the kit is now available for shipment.

Growers, agronomists and other professionals managing vineries will be able to test their vine grapes in as little as 30 min.

Please refer to the product brochure you can download from our website for full product info and notices.

Posted in bKIT, Products

Newsletter

Subscribe our newsletter for periodical updates about Hyris solutions.

Address


Headquarter

London

Lower Ground Floor
One George Yard
EC3V 9DF - London, UK
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Research Center

Milan

Viale Lancetti 19
20158 Milan, Italy

  • This email address is being protected from spambots. You need JavaScript enabled to view it.

C.so Garibaldi 60
Milano 20121, Italy
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Hyris APAC - R&D Center of Excellence

Singapore

38 19 Cecil Street #04-01
The Quadrant at Cecil
Singapore (049704)
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

US West Coast Sales Inquiries

Los Gatos

  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Social